Company: ENTXW
Filing Date: 2025-05-30
Form Type: S-8
Source: 0001178913-25-002027
Chunk: 0

Company: Entera Bio Ltd.
Filing Date: 2025-05-30
Form: S-8
Chunk 0
---
As filed with the Securities and Exchange Commission on May 30, 2025 Registration No. 333-_____ UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Entera Bio Ltd.
(Exact name of registrant as specified in its charter)

| State of Israel                                                | Not Applicable                      |
| (State or other jurisdiction of incorporation or organization) | -I.R.S. Employer Identification No. |
| Kiryat HadassahMinrav Building – Fifth Floor                   
 Jerusalem, Israel                                              
 (Address of Principal Executive Offices)                       | 9112002                             
 (Zip Code)                          |

Entera Bio Ltd. 2018 Equity Incentive Plan (Full title of the plan) Gerald Lieberman Director 19 Old Woods Drive Harrison, New York 10528 (Name and address of agent for service) (917) 684-1558 (telephone number, including area code, of agent for service) Copies to: Drew M. Altman, Esq. Sami B. Ghneim, Esq. Greenberg Traurig, P.A. 333 S.E. 2nd Avenue, Suite 4400 Miami, Florida 33131 (305) 579-0500 Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.:

| Large accelerated filer | ☐ | Accelerated filer         |     | ☐ |
| Non-accelerated filer   | ☒ | Smaller reporting company |     | ☒ |
|                         |   | Emerging growth company   |     | ☐ |

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐ STATEMENT OF INCORPORATION BY REFERENCE This Registration Statement is filed by Entera Bio Ltd. (the “ Registrant”) for the purpose of registering additional ordinary shares, par value NIS 0.